These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33740593)

  • 1. Metabolic profile in patients with narcolepsy: a systematic review and meta-analysis.
    Mohammadi S; Moosaie F; Saghazadeh A; Mahmoudi M; Rezaei N
    Sleep Med; 2021 May; 81():268-284. PubMed ID: 33740593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body Weight and Metabolic Rate Changes in Narcolepsy: Current Knowledge and Future Directions.
    Dhafar HO; BaHammam AS
    Metabolites; 2022 Nov; 12(11):. PubMed ID: 36422261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines in narcolepsy: A systematic review and meta-analysis.
    Mohammadi S; Mayeli M; Saghazadeh A; Rezaei N
    Cytokine; 2020 Jul; 131():155103. PubMed ID: 32315956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).
    Bassetti C; Gugger M; Bischof M; Mathis J; Sturzenegger C; Werth E; Radanov B; Ripley B; Nishino S; Mignot E
    Sleep Med; 2003 Jan; 4(1):7-12. PubMed ID: 14592354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy.
    Nishino S; Ripley B; Overeem S; Nevsimalova S; Lammers GJ; Vankova J; Okun M; Rogers W; Brooks S; Mignot E
    Ann Neurol; 2001 Sep; 50(3):381-8. PubMed ID: 11558795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Untangling narcolepsy and diabetes: Pathomechanisms with eyes on therapeutic options.
    Mohammadi S; Dolatshahi M; Zare-Shahabadi A; Rahmani F
    Brain Res; 2019 Sep; 1718():212-222. PubMed ID: 30998932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.
    Mignot E; Lammers GJ; Ripley B; Okun M; Nevsimalova S; Overeem S; Vankova J; Black J; Harsh J; Bassetti C; Schrader H; Nishino S
    Arch Neurol; 2002 Oct; 59(10):1553-62. PubMed ID: 12374492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans.
    Kok SW; Meinders AE; Overeem S; Lammers GJ; Roelfsema F; Frölich M; Pijl H
    J Clin Endocrinol Metab; 2002 Feb; 87(2):805-9. PubMed ID: 11836325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired histaminergic neurotransmission in children with narcolepsy type 1.
    Franco P; Dauvilliers Y; Inocente CO; Guyon A; Villanueva C; Raverot V; Plancoulaine S; Lin JS
    CNS Neurosci Ther; 2019 Mar; 25(3):386-395. PubMed ID: 30225986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of narcolepsy on olfactory function: a review.
    de Martin Truzzi G; Naufel MF; Tufik S; Coelho FM
    Sleep Med; 2020 Aug; 72():75-81. PubMed ID: 32554327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Narcolepsy in Parkinson's disease.
    Haq IZ; Naidu Y; Reddy P; Chaudhuri KR
    Expert Rev Neurother; 2010 Jun; 10(6):879-84. PubMed ID: 20518604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced leptin levels in human narcolepsy.
    Schuld A; Blum WF; Uhr M; Haack M; Kraus T; Holsboer F; Pollmächer T
    Neuroendocrinology; 2000 Oct; 72(4):195-8. PubMed ID: 11070422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
    Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H
    Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal Morning Melanin-Concentrating Hormone Levels and No Association with Rapid Eye Movement or Non-Rapid Eye Movement Sleep Parameters in Narcolepsy Type 1 and Type 2.
    Schrölkamp M; Jennum PJ; Gammeltoft S; Holm A; Kornum BR; Knudsen S
    J Clin Sleep Med; 2017 Feb; 13(2):235-243. PubMed ID: 27855741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin and metabolic syndrome in obese and non-obese children.
    Moreno LA; Pineda I; Rodríguez G; Fleta J; Giner A; Juste MG; Sarría A; Bueno M
    Horm Metab Res; 2002 Jul; 34(7):394-9. PubMed ID: 12189588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lateral hypothalamic lesion with the neurotoxin hypocretin-2-saporin on sleep in Long-Evans rats.
    Gerashchenko D; Blanco-Centurion C; Greco MA; Shiromani PJ
    Neuroscience; 2003; 116(1):223-35. PubMed ID: 12535955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity.
    Kok SW; Overeem S; Visscher TL; Lammers GJ; Seidell JC; Pijl H; Meinders AE
    Obes Res; 2003 Sep; 11(9):1147-54. PubMed ID: 12972686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPLC analysis of CSF hypocretin-1 in type 1 and 2 narcolepsy.
    Sakai N; Matsumura M; Lin L; Mignot E; Nishino S
    Sci Rep; 2019 Jan; 9(1):477. PubMed ID: 30679597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypocretins (orexins) and sleep-wake disorders.
    Baumann CR; Bassetti CL
    Lancet Neurol; 2005 Oct; 4(10):673-82. PubMed ID: 16168936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep/wake fragmentation disrupts metabolism in a mouse model of narcolepsy.
    Zhang S; Zeitzer JM; Sakurai T; Nishino S; Mignot E
    J Physiol; 2007 Jun; 581(Pt 2):649-63. PubMed ID: 17379635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.